Amgen is a leading American multinational biopharmaceutical company that focuses on discovering, developing, and delivering innovative human therapeutics. Established in 1980 and headquartered in Thousand Oaks, California, Amgen has grown into one of the largest independent biotechnology companies in the world. The company specializes in using advanced science and biotechnology to create medicines for serious illnesses such as cancer, kidney disease, rheumatoid arthritis, cardiovascular disease, and other life-threatening conditions. Amgen is well known for its strong research and development efforts, with a commitment to advancing biotechnology to improve patients’ lives. Its portfolio includes both biologic medicines and biosimilars, and the company continues to play a major role in shaping the future of healthcare through innovation and cutting-edge treatments.